CYTEK BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
CYTEK BIOSCIENCES, INC. (CTKB) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of -12.90% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2024-03-13
- CYTEK BIOSCIENCES, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2023 was -12.90%, a 108.81% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2022 was 146.40%, a 2118.18% increase from fiscal 2021.
- CYTEK BIOSCIENCES, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2021 was 6.60%, a 175.00% increase from fiscal 2020.
- CYTEK BIOSCIENCES, INC. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2020 was 2.40%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month |
|---|---|
| 2023-12-31 | -12.90% 10-K · filed 2024-03-13 |
| 2022-12-31 | 146.40% 10-K · filed 2024-03-13 |
| 2021-12-31 | 6.60% 10-K · filed 2024-03-13 |
| 2020-12-31 | 2.40% 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |